Essex Financial Services Inc. Sells 49 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Essex Financial Services Inc. trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,792 shares of the medical equipment provider’s stock after selling 49 shares during the quarter. Essex Financial Services Inc.’s holdings in Intuitive Surgical were worth $935,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in ISRG. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. Godsey & Gibb Inc. lifted its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the third quarter worth $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical in the third quarter valued at $38,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,348 shares of company stock worth $3,587,582. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $591.65 on Wednesday. The business’s fifty day moving average is $555.91 and its 200-day moving average is $515.92. The stock has a market capitalization of $210.73 billion, a price-to-earnings ratio of 92.30, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on ISRG. Citigroup increased their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Evercore ISI boosted their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a report on Friday, October 18th. Finally, CICC Research initiated coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price target for the company. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.